Saline breast implant research
This article was originally published in The Gray Sheet
Executive Summary
Potential autoimmune reaction to breast implants may be linked to the implants' silicone shell and not the contents of the prostheses, Henry Claman, MD, University of Colorado Health Sciences Center, Denver, reports to FDA. Both saline- and silicone gel-filled breast implants employ a silicone shell. In Jan. 26 comments on FDA's proposed call for saline-filled breast implants, Claman says his study results found that "there was no correlation between antinuclear antibody [ANA] positivity," which indicates autoimmune response, and the type of implant. "Thus, a positive ANA might be related to the silicone shell rather than the contents." Claman's research on over 100 patients recently was submitted to the Western Journal of Medicine.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.